Imagene AI: Funding, Investors & Team (Sep 2026)
Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy. Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients. Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.
Imagene AI has raised $41.5M across 2 funding rounds on record, the most recent a Series B of $23.0M announced in Jul 2025.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Imagene AI Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Imagene AI Funding Rounds
Imagene AI raised $18.5M in a Series A announced in May 2022.
3.2 years later, a Series B of $23.0M was announced in Jul 2025.
Imagene AI Founders and Leadership Team
Contact details for the Imagene AI team: 1 of 1 has an email address on file.
Start 14-day free trial →Imagene AI Funding Compared to Other Artificial Intelligence Startups
Imagene AI's latest round of $23.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Imagene AI in Artificial Intelligence and Tel Aviv
Companies Similar to Imagene AI
Faye provides whole-trip travel coverage and care that brings out the best in each journey with…
Arato.ai is an advanced AI agent simulation platform that helps organizations test, evaluate, and monitor…
Kinoa provides an AI-powered LiveOps platform that helps mobile app and game companies manage user…
Dream Security is a cybersecurity firm that creates artificial intelligence products to safeguard against…
SuperBuzz (TSXV: SPZ) utilizes cutting-edge GPT-3 technology, such as chatGPT, to produce targeted content…
Limitless Labs is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM…
NewCore is a security-first identity platform that governs every human and AI agent identity for the…
Odysight.AI is an AI platform that specializes in visualizing, analyzing, predictive maintenance, and…
Arito is an AI-powered finance platform that helps teams automate reporting, analyze data, and generate…
Cybord creates technologies that prevent fake, substandard, and harmful electronic parts from being…
The ThirdEye Team believes that today's drones have amazing capabilities and should be accessible by almost…
The unique computational solution provided by Scala Biodesign enhances the worth of proteins and speeds up…
Imagene AI Funding FAQs
What does Imagene AI do?
Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy. Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients. Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.
How much funding has Imagene AI raised?
Imagene AI has raised $41.5M across 2 rounds on record. The most recent is a Series B of $23.0M announced in Jul 2025.
When did Imagene AI last raise funding?
Imagene AI's most recent funding round on record is a Series B of $23.0M, announced in Jul 2025.
Who founded Imagene AI?
FundedIQ lists Jonathan Zalach (Founder) at Imagene AI.
Where is Imagene AI headquartered?
Imagene AI is based in Tel Aviv, Israel.
How many employees does Imagene AI have?
Imagene AI is in the 11-50 employee band.
How does Imagene AI's funding compare to other Artificial Intelligence startups?
Imagene AI's latest round of $23.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Imagene AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Imagene AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.